Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Section 5: Patient Safety and Quality Assurance
5PSQ-008
RESULTS AFTER THE IMPLANTATION OF AN INSULINISATION PROTOCOL IN NON-CRITICAL HOSPITALISED PATIENTS
5PSQ-001
ANAEMIA AMONG HOSPITALISED ELDERLY PATIENTS
5PSQ-118
A MEDICATION RECONCILIATION PROTOCOL PERFORMED BY PHARMACISTS: IMPACT ON HOSPITAL DISCHARGE SUMMARIES
5PSQ-138
BEST PRACTICE OF WARD-BASED RECONSTITUTION IN PAEDIATRIC HOSPITALS
5PSQ-115
COMPUTERISED PHYSICIAN ORDER ENTRY IMPACT ON MEDICATION ERRORS IN A PAEDIATRIC UNIT
5PSQ-134
HYPERPIGMENTATION INDUCED BY PROLONGED USE OF CHLOROQUINE: A CASE REPORT
5PSQ-133
PREVALENCE OF UNDERPRESCRIPTION OF RECOMMENDED MEDICATIONS IN FRAIL AND ROBUST OLDER ADULTS IN NURSING HOMES
5PSQ-132
CASES OF DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOM SYNDROME DUE TO ANTIINFLAMMATORY DRUGS
5PSQ-131
MOBILE APPLICATIONS TO CHECK DRUG INTERACTIONS: QUALITATIVE AND QUANTITATIVE ANALYSIS
5PSQ-121
PHARMACEUTICAL INTERVENTION IN CONCILIATION PERFORMED IN AN EMERGENCY DEPARTMENT
5PSQ-114
FREQUENCY OF MANIPULATED MEDICINES ADMINISTERED TO PAEDIATRIC IN-PATIENTS: A REGISTER STUDY
5PSQ-107
TABLET CRUSHING AND HARD CAPSULE OPENING PRACTICES IN NURSING HOME AND LONG-TERM CARE UNIT
5PSQ-102
HAZARDOUS DRUG COLOUR MARKS THE DIFFERENCE
5PSQ-099
CYTOTOXIC PREPARATION UNIT: EVALUATION OF CLINICAL SERVICES SATISFACTION IN THREE HOSPITALS
5PSQ-095
LIKELY HYPERSENSIVILITY TO 20% AUTOLOGOUS SERUM EYE DROPS
Pages
« first
‹ previous
…
53
54
55
56
57
58
59
60
61
next ›
last »
Follow Us